BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10745179)

  • 1. Induction of apoptosis in KB cells by pingyangmycin.
    Tai KW; Chou MY; Hu CC; Yang JJ; Chang YC
    Oral Oncol; 2000 Mar; 36(2):242-7. PubMed ID: 10745179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
    Ho YC; Tai KW; Chang YC
    Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of pingyangmycin on cultured KB cells.
    Tai KW; Chang YC; Chou LS; Chou MY
    Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
    Gong JH; Liu XJ; Li Y; Zhen YS
    Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between intracellular glutathione level and the mode of cell death induced by pingyangmycin.
    Tai KW; Lii CK; Chou MY; Chang YC
    Oral Oncol; 2003 Jan; 39(1):13-8. PubMed ID: 12457716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
    Wang WG; Wang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
    Sun ML; Wang CM; Wen YM
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
    Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of pingyangmycin-induced apoptosis of cultured human umbilical vein endothelial cells.
    Huang YD; Tong X; Chen Q; Xia SW; Zhuo Y; Kang ZH; Xue XY
    Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of pingyangmycin on the growth and differentiation of the transplantable squamous cell carcinoma of forestomach (GS-742) in mice].
    Wang FR
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):326-8. PubMed ID: 2482804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
    Dai Y; Liu XJ; Zhen YS
    Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.
    Okamura H; Morimoto H; Haneji T
    Oral Oncol; 2001 Jun; 37(4):379-85. PubMed ID: 11337271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
    Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
    FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells].
    Kong WD; Li YH; Zeng QL; Chen Y; He XF
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
    Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
    Chen CJ; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):519-24. PubMed ID: 16288335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
    Liu X; Zhen Y
    Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of mitogen-activated protein kinase (MAPK) pathway in the action mechanism of PYM-induced KB cells apoptosis].
    Dai G; Zhang Z; Zhou M; Yu S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):97-8. PubMed ID: 12475417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticancer spectrum of pingyangmycin in vitro].
    Li XT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):182-6. PubMed ID: 1706647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.